EGFR as a potent CAR T target in triple negative breast cancer brain metastases. Subham S, Jeppson JD, Worcester C, Schatmeyer B, et al. Breast Cancer Res Treat 2022 Nov 1. pii: 10.1007/s10549-022-06783.

Read + Share

Amedeo Smart

Independent Medical Education

Subham S, Jeppson JD, Worcester C, Schatmeyer B, et al. EGFR as a potent CAR T target in triple negative breast cancer brain metastases. Breast Cancer Res Treat 2022 Nov 1. pii: 10.1007/s10549-022-06783.
PMID: 36318382